Damien Hirst Spiritual Day Blossom 2018
Someone tweeted this graph and said: early treatment can’t be far off.
John P.A. Ioannidis, MD, DSC, Stanford University: Could we reach a point where we WISH the next year to be one predominantly SARS-CoV-2 rather than influenza? pic.twitter.com/FQ2IZqTx4P
— Husserl (@husserl80) July 6, 2021
Just the fact that they feel they need to re-state it says enough.
With a new round of data out of Israel seemingly confirming what we have been reporting for weeks now, fresh questions are emerging about the efficacy of the mRNA vaccines (those produced by Pfizer and Moderna) and whether they’re truly 90%+ effective, as advertised. As the number of confirmed COVID cases topped 184MM, the Israeli health ministry shared preliminary data appearing to confirm that these vaccines are less effective at preventing infection via the Delta variant. Although the data must still be peer reviewed, the Israelis went so far as to proclaim that the true efficacy number is closer to 64%. To be sure, the vaccines continue to mostly prevent severe infection and death (though they’re only 93% effective at this, less than the 100% number initially touted by their corporate parents).
Now, with President Joe Biden publicly addressing the administration’s ongoing effort to combat COVID as case numbers continue to creep higher in the US, the CDC has chimed in – right on cue – to remind the world that the benefits of everybody taking the vaccine still far outweigh the risks posed by the rare (but sometimes deadly) side effects that have now also been documented. As we reported, the FDA now recognizes that the rare heart inflammation seen in some patients, including members of the military, have been linked to mRNA vaccines. So, with criticism and skepticism directed at the US-made vaccines mounting, the CDC on Tuesday tried its hand at a little damage control.
Per Bloomberg: “The benefits of messenger RNA Covid-19 vaccines clearly outweigh the risks despite heart complications seen in a relatively small number of mostly young men, according to the U.S. Centers for Disease Control and Prevention. Roughly 1,200 cases of myocarditis, or inflammation of the heart wall, were reported in people who received mRNA vaccines, the CDC said in its Morbidity and Mortality Weekly Report on Tuesday. But with about 296 million doses of mRNA vaccines having been administered as of June 11, the benefit is clear in all populations, including adolescents and young adults, the researchers reported.”
For the Biden Administration, the stakes have never been higher. COVID cases are rising, and many are blaming Southern and western states with lower vaccination rates as a potential vulnerability that could ignite another wave of COVID.
Tucker life expectancy
TUCKER: "The data show that the median age of death for COVID is often older than life expectancy … Do you think they hyped COVID a little bit? Yeah, they did."
— Election Wizard (@ElectionWiz) July 7, 2021
Reaction? More lockdowns. Which have failed for 18 months now. And what are they trying to achieve? How long can you separate the entire country from the world? Until you reach zero, and then you can open and start all over again?
The world’s most transmissible Covid-19 strain has found its way into Australia – with worrying research revealing it may be even more infectious than the Delta variant. The Lambda strain has puzzled World Health Organisation scientists after it spread to nearly 30 countries in the last four weeks. The mutation was originally discovered in Peru and is related to 81 per cent of the country’s cases since April. Peru currently has the highest Covid mortality rate in the world. In Australia, the variant was detected in an overseas traveller who had been in hotel quarantine in New South Wales in April, according to national genomics database AusTrakka. Early research shows it has not spread among the community in Australia.
Lambda has just started to make its way into the community in the UK, with six cases reported on Monday. It is a worrying sign for the UK, which has recently relaxed Covid-19 restrictions after 37 million people received at least one dose of a vaccine. The country had returned to normality in recent weeks, with pubs flooded by revellers enjoying their country’s recent success at Euro 2020. However, these civil liberties could change if the highly transmissible Lambda strain spreads across the community. Professor Pablo Tsukayama of Cayetano Heredia University in Lima, Peru, said the strain has exploded in Peru, suggesting “its rate of transmission is higher than any other variant”. His claims were backed up by a report by Jeff Barrett from London’s Covid-19 Genomics Initiative at the Welcome Sanger Institute.
“Lambda has a unique pattern of seven mutations in the spike protein that the virus uses to infect human cells. Researchers are particularly intrigued by one mutation called L452Q, which is similar to the L452R mutation to contribute to the high infectiousness of the Delta variant,” Barrett told the Financial Times. There is also concerning research that current vaccines are not as effective in neutralising the new strand, according to a report from scientists at the University of Chile in Santiago. “Our data show for the first time that mutations present in the spike protein of the Lambda variant confer escape to neutralising antibodies and increased infectivity,” they wrote in a pre paper report published last week.
official Product Information file from the European Medicines Agency
Many people have already taken the AstraZeneca vaccine, or want to take it. So I thought I’d read its official Product Information file from the European Medicines Agency. Some might call this “the small print”. Here is what I learned: Firstly, is it safe for children? “The safety and efficacy of Vaxzevria in children and adolescents (less than 18 years of age) have not yet been established. No data are available.” How about people with weak immune symptoms – is it safe for them? “The efficacy, safety and immunogenicity of the vaccine have not been assessed in immunocompromised individuals, including those receiving immunosuppressant therapy. How long does protection last? The EMA says that ongoing clinical trials will tell us: “The duration of protection afforded by the vaccine is unknown as it is still being determined by ongoing clinical trials.”
How about older people – will the vaccine work for them? Many of them have already taken it, of course. This is what the document says: “Currently available clinical trial data do not allow an estimate of vaccine efficacy in subjects over 55 years of age.” Sounds important! And for pregnant women: “There is limited experience with use of Vaxzevria in pregnant women. Animal reproductive toxicity studies have not been completed. Based upon results from the preliminary study, no effects are expected on development of the fetus.” Again, later in the document: “Animal studies of potential toxicity to reproduction and development have not yet been completed. A preliminary reproductive toxicity study in mice does not show toxicity in dams or foetuses.” Hopefully the animal trials will show it is safe!
How about studies relating to the risk of cancer and genetic mutations? “Neither genotoxicity nor carcinogenicity studies were performed. The components of the vaccine are not expected to have genotoxic potential.” Adverse reactions: – headache (52.7%) – fatigue (53.0%) – muscle pain (43.9%) – malaise (44.4%) – feverishness (33.5%), fever (7.6%), – chills (32.2%) – joint pain (26.6%) – nausea (22.2%). Most reactions were “mild to moderate in severity and usually resolved within a few days” And now the results: In the control group, 3% suffered “Covid” with at least one symptom. In the vaccinated group, 1.2% suffered “Covid” with at least one symptom. None of the vaccinated group were hospitalised by Covid, versus 0.2% of the control group (8 people out of 5,210) It has the medical equivalent of a provisional driving licence: “This medicinal product has been authorised under a so-called ‘conditional approval’ scheme. This means that further evidence on this medicinal product is awaited.”
“I’ve been contacted by members of our voluntary military who say they will quit if the COVID vaccine is mandated”
Rep. Thomas Massie (R-Ky.) said he was informed by some members of the U.S. military that they would quit if the armed forces mandated a COVID-19 vaccine, coming after a report claimed that Army headquarters told commanders to prepare for mandatory vaccinations in September. “I’ve been contacted by members of our voluntary military who say they will quit if the COVID vaccine is mandated. I introduced HR 3860 to prohibit any mandatory requirement that a member of the Armed Forces receive a vaccination against COVID-19. It now has 24 sponsors,” Massie wrote on Twitter. He didn’t provide more details.
It isn’t clear how the service members could quit or how many would try to do so. Once a member reports to their first duty station, they are obligated to stay within the service of the armed forces. If a service member leaves without approval, they can be declared AWOL, or absent without leave. The Republican lawmaker was referring to a report published by the Army Times over the weekend that detailed an executive order sent by the Department of the Army Headquarters that commands should be prepared to administer COVID-19 vaccines starting as early as Sept. 1. The date is contingent on when the Food and Drug Administration (FDA) issues its full approval of the vaccines. The Army Times reported that it had obtained the directive, HQDA EXORD 225-21, COVID-19 Steady State.
“Commanders will continue COVID-19 vaccination operations and prepare for a directive to mandate COVID-19 vaccination for service members [on or around] 01 September 2021, pending full FDA licensure. Commands will be prepared to provide a backbrief on servicemember vaccination status and way ahead for completion once the vaccine is mandated,” the directive reads. An EXORD is a directive issued by the president to the defense secretary to execute a military operation.
Didn’t see this about quercetin before. We use it to make sure zinc gets into the cell.
The current pandemic, known as coronavirus disease 2019 (COVID-19) triggered by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is provoking devastating health, psychological and financial consequences worldwide.1–3 Although several vaccines have been developed, due to limitation in their manufacturing and distribution capacities, the desired globally “herd immunity” still appears to be a distant mirage. In addition, the constant mutations in SARS-CoV-2 put the effectiveness of these vaccination campaigns at serious risk regardless of its speed.4 The current antivirus agents being used, including hydroxychloroquine, ivermectin, lopinavir/ritonavir, have not shown any conclusive benefits.
New possible treatments that are safe, affordable, and worldwide available targeting the SARS-CoV-2 are therefore urgently required.6 SARS-CoV-2 proteases, like 3-chymotrypsin-like protease (3CLpro), papain-like protease (PLpro), RNA-dependent RNA polymerase, spike (S) protein and human angiotensin-converting enzyme 2 (hACE2) are considered possible targets for developing effective anti-COVID-19 drugs.7 Recently, molecular docking studies have suggested the possible binding interaction of quercetin with the 3CLpro, PLpro, and S-hACE2 complex.8–12 Some recent results, obtained by biophysical techniques, appear to support the results of the molecular docking studies.
Quercetin, a flavonol not naturally present in the human body, is the most abundant polyphenol in fruits and vegetable and is widely used as a dietary supplement to boost the immune system and promote a healthy lifestyle. Quercetin is characterized by three crucial properties: antioxidant, anti-inflammatory and immunomodulatory. The combination of these actions allows quercetin to be a potential candidate to support all unhealthy conditions where oxidative stress, inflammation and immunity are involved.
That’s not much.
On Friday, Santa Clara County health leaders announced a drop in its COVID-19 death toll by nearly a quarter after it refined its approach in reporting the data. The county reported that it had reviewed each COVID-19 fatality and was only counting those whose cause of death was from the virus and not those who tested positive for COVID-19 at the time of death but did not necessarily die from the virus. The new approach meant that the death toll dropped by 22%, specifically from 2,201 to 1,696 deaths. “It is important to go back and do this accounting to see if COVID was actually the cause of death,” said University of California San Francisco Prof. of Medicine and Infectious Disease expert Dr. Monica Gandhi.
“I think that transparent communication is an upside, I mean, in the sense that it’s true that if we did this across the nation, it would bring our death rate lower. A downside of that, could be that people will say, ‘Well, it wasn’t as serious as you said.’” The refined approach in Santa Clara County comes as county officials try to figure out the true impact of the virus on the community. Last month, Alameda County health leaders refined their approach to reporting COVID-19 deaths as well and also registered a drop in that county’s death toll by about a quarter. “In the midst of everything COVID people were sort of putting down that cause of death as COVID,” Gandhi said. “It is important to go back and do this accounting to see if COVID was actually the cause of death.”
Why break patents of experimental drugs?
The lower house of the Brazilian Congress has voted for a bill that would legalize the violation of patents for vaccines and medications in the event of a national health emergency. It will now go back to the Senate for approval. On Tuesday, the Chamber of Deputies voted 425 to 15 in favor of PL 12/2021. Sponsored by Aécio Neves da Cunha, a Social Democrat from Minas Gerais, the bill would authorize Congress to issue patent-breaking licenses “in case of a public health emergency,” without the approval of the head of state. President Jair Bolsonaro has opposed the proposal. The bill will now return to the Senate, which will decide whether to approve amendments adopted during Chamber debate. “There is an understanding that the changes… we introduced in the bill will also be incorporated in the Senate, which will maintain the text that we have negotiated here,” Neves said, according to Reuters.
One significant difference from the original is that patent holders will no longer be required to provide biological material to companies licensed to violate intellectual property under the emergency rules. The provision was declared “impractical,” “arbitrary” and in violation of Brazil’s constitutionally guaranteed principle of free enterprise. Another amendment would see IP holders compensated to the tune of 1.5% of the net sales involving the infringed medication or vaccine. The law was hailed by the Brazilian branch the NGO Doctors Without Borders (MSF). The measure “improves the current patent law, authorizing the application of compulsory licensing in a more complete and efficient manner, in this health emergency and others,” said MSF’s Brazilian coordinator Felipe Carvalho.
“You can’t get a city district attorney indicting somebody for failing to pay federal income taxes when the IRS hasn’t even gone after him..”
Harvard Law professor emeritus Alan Dershowitz says he believes federal tax fraud charges filed in New York City against The Trump Organization’s longtime finance chief will end up being dismissed. “You can’t get a city district attorney indicting somebody for failing to pay federal income taxes when the IRS hasn’t even gone after him,” Dershowitz said in a July 3 interview with Newsmax. “One of the charges, a major charge, is grand larceny against the United States government. “That shows the extent to which they are prepared to stretch existing law and the Constitution to give them authority over federal taxes. It’s absurd.”
On July 1, The Trump Organization and its chief financial officer, Allen Weisselberg, were charged in what New York prosecutors called a “sweeping and audacious” tax fraud scheme in which Trump’s company and Weisselberg allegedly cheated the state and city out of taxes by conspiring to pay senior executives off the books by way of fringe benefits, such as apartment rent and car payments. Prosecutor Carey Dunne said in court that the alleged scheme was “orchestrated by the most senior executives” at the firm and got “secret pay raises at the expense of state and federal taxpayers.” Weisselberg and attorneys for The Trump Organization have pleaded not guilty.
Ahead of the unsealing of the criminal indictment on July 1, The Trump Organization criticized Manhattan prosecutors for what they claimed was a partisan criminal investigation designed to hurt Trump politically. In a July 1 statement, The Trump Organization said the probe “is not justice; this is politics.” Dunne pushed back on the claim, saying that “politics has no role in the jury chamber, and I can assure you it had no role here.” Alan Futerfas, a member of The Trump Organization’s defense team, disagreed. “I believe the political forces driving today’s events are just that. It’s political, politically driven, notwithstanding the statements by my colleague at the DA’s office in court today,” Futerfas said.
The Fed will end the US if the US doesn’t end the Fed first.
“The ‘wealth effect’ is the notion that when households become richer as a result of a rise in asset values, such as corporate stock prices or home values, they spend more and stimulate the broader economy,” the NBER said. And yes, after making about 10% of the population a lot richer and producing immense concentration of wealth at the top 1%, there are some minor trickle-down effects on the rest of the economy. Meanwhile, the already immense wealth disparity in the US between the top 10% and the bottom 50% – or worse still, the top 1% and the bottom 50% – blows out. Turns out, the lower 50% of Americans holds practically no stocks, no bonds, and very little real estate, according to the wealth distribution data from the Federal Reserve.
And these folks cannot benefit at all from the wealth effect. For them, life (such as housing) just gets more expensive as a result of the wealth effect. From the Federal Reserve’s data, as of Q1 2021: – The average household in the richest 10% owns $2.6 million in stocks and $1.2 million in real estate. – The average household in the richest 1% holds $16 million in stocks and $4 million in real estate. – The average household in the bottom 50% holds essentially no stocks, no bonds, and only small amounts of real estate. The wealthiest 1% is where the real concentration of wealth takes place. – The wealthiest 15 US individuals have a combined wealth of $2 trillion, according to the Bloomberg Billionaires Index (June 2021). They benefit more than anyone from the wealth effect.
The Wealth Effect purposefully increases asset prices. But only the top 10% of households have significant amounts in assets. The bottom 50% hold nearly no stocks because they don’t make enough money to put anything aside. Many of these people live from paycheck to paycheck. But the Wealth Effect also makes housing more expensive – both buying and renting – and thereby the bottom 50% disproportionately pay for the Wealth Effect. For the bottom 50%, the Wealth Effect is a negative. This chart is from my Wealth Effect Monitor.
We try to run the Automatic Earth on donations. Since ad revenue has collapsed, you are now not just a reader, but an integral part of the process that builds this site. Thank you for your support.
The best way to keep a prisoner from escaping is to make sure he never knows he’s in prison.
– Fyodor Dostoevsky
Best Selfie Ever
— Ruptures (@Ruptures_fr) July 6, 2021
Support the Automatic Earth in virustime. Click at the top of the sidebars to donate with Paypal and Patreon.